Technology areas: Biotechnology & Pharmaceuticals • Chemistry & Materials
2 pending office actions • 2 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready
Cupron Inc. is managing 2 pending office actions within the Chemistry & Materials technology area. The prosecution work is spread across 2 distinct examiners and 2 distinct art units, which indicates that the company's applications are being evaluated by different specialized groups. This lack of concentration suggests that the underlying technology may span multiple chemical or material classifications. Navigating 2 distinct art units often requires adapting to different examination standards and timelines within the USPTO.
The busiest examiner for this portfolio is BEHRENS JR., ANDRES E, who is responsible for 1 pending office action. Because there are 2 distinct examiners for the 2 pending actions, each examiner is currently handling exactly one matter. This even distribution means that no single examiner has a dominant influence over the company's current pending portfolio. For the applicant, this provides a diversified risk profile, as the success of the portfolio is not tied to the decisions of a single individual or art unit.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (50%) |
| Multi-statute (no §101) | 1 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| BEHRENS JR., ANDRES E | 1 | 52.9% | +18.8% |
| HELM, CARALYNNE E | 1 | 28.9% | +49.6% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18681804 | Antimicrobial, Antiviral and Antifungal Articles and Methods of Producing Such Articles | HELM, CARALYNNE E | 12d |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18681804 | Antimicrobial, Antiviral and Antifungal Articles and Methods of Producing Such Articles | HELM, CARALYNNE E | 12d |
| 18692668 | FIBERS WITH EMBEDDED PARTICLES AND METHODS OF PRODUCING FIBERS WITH EMBEDDED PARTICLES | BEHRENS JR., ANDRES E | — |
| Art Unit | Apps |
|---|---|
| 1741 | 1 |
| 1615 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18692668 | FIBERS WITH EMBEDDED PARTICLES AND METHODS OF PRODUCING FIBERS WITH EMBEDDED PARTICLES | BEHRENS JR., ANDRES E | 1741 | §103 | Final Rejection | — | Pending | Mar 15, 2024 |
| 18681804 | Antimicrobial, Antiviral and Antifungal Articles and Methods of Producing Such Articles | HELM, CARALYNNE E | 1615 | §102§103§112Other | Non-Final OA | 12d | Pending | Feb 06, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial